SEC Form 4 · Insider disclosures

Insider Trading Tracker

Who bought, who sold, and the disclosed plans and ownership context behind recent SEC Form 4 filings.

Updates are delayed; the last verified disclosures remain available.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

429 companies · 1,925 rows
SCISX

MA Specialty Credit Income Fund

Total value ≈ US$2.4M

1 transaction rows · 1 filings

MA Eagle II Holdings Fund

Purchase
10% owner disclosed purchase of 96,930.533 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 2.71%; approximately 3.67M shares afterward

Calculated transaction value approximately US$2.4M
Total value ≈ US$102.98K

6 transaction rows · 5 filings

do Carmo Thomaz Junior Geraldo

Sale
CEO disclosed sale of 4,808 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.42% of prior direct holdings; approximately 1.13M shares remain

Calculated transaction value approximately US$19.66K

Gomide de Faria Mariano

Sale
CEO disclosed sale of 4,808 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.52% of prior indirect holdings; approximately 904K shares remain

Calculated transaction value approximately US$19.71K
Show 4 more transaction rows

Gomes Andre Spolidoro Ferreira

Sale
Officer disclosed sale of 3,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 303K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$12.57K

Gomes Andre Spolidoro Ferreira

Sale
Officer disclosed sale of 3,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 27.4K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$12.57K

do Carmo Thomaz Junior Geraldo

Sale
CEO disclosed sale of 4,808 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.42% of prior direct holdings; approximately 1.14M shares remain

Calculated transaction value approximately US$19.23K

Gomide de Faria Mariano

Sale
CEO disclosed sale of 4,808 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.52% of prior indirect holdings; approximately 909K shares remain

Calculated transaction value approximately US$19.23K
ISBA

ISABELLA BANK CORP

Total value ≈ US$300

1 transaction rows · 1 filings

Bourland Jill

Purchase
Director disclosed purchase of 8.1722 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.13%; approximately 5.93K shares afterward

Calculated transaction value approximately US$300
XGN

EXAGEN INC.

Total value ≈ US$374.23K

2 transaction rows · 2 filings

Chernett Jorey

Purchase
10% owner disclosed purchase of 14,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.53%; approximately 2.62M shares afterward

Calculated transaction value approximately US$104.44K

ABALLI JOHN

Sale
CEO / Director disclosed sale of 34,294 shares

Filing did not check the 10b5-1 plan indicator

Sale represented approximately 4.08% of prior direct holdings; approximately 806K shares remain

Calculated transaction value approximately US$269.79K
NNOX

Nano-X Imaging Ltd.

Total value ≈ US$11.25K

1 transaction rows · 1 filings

Meltzer Erez

Purchase
CEO / Director disclosed purchase of 25,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 38.20%; approximately 90.4K shares afterward

Calculated transaction value approximately US$11.25K
IONS

IONIS PHARMACEUTICALS INC

Total value ≈ US$61.39K

2 transaction rows · 2 filings

Devers Shannon L.

Sale
Officer disclosed sale of 1,357 shares

Filing did not check the 10b5-1 plan indicator

Approximately 17.8K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$59.08K

Swayze Eric

Sale
Officer disclosed sale of 53 shares

Filing did not check the 10b5-1 plan indicator

Approximately 390 shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.31K
GRAB

Grab Holdings Ltd

Total value ≈ US$238.95K

2 transaction rows · 2 filings

Oey Peter Henry

Sale
CFO disclosed sale of 50,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.73% of prior direct holdings; approximately 6.75M shares remain

Calculated transaction value approximately US$148.95K

Kandal Philipp Wolfgang Josef

Sale
Officer disclosed sale of 30,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 0.75% of prior direct holdings; approximately 3.93M shares remain

Calculated transaction value approximately US$90K
DLPN

Dolphin Entertainment, Inc.

Total value ≈ US$4.92K

1 transaction rows · 1 filings

O'Dowd William IV

Purchase
CEO / Director / 10% owner disclosed purchase of 4,700 shares

Disclosed 10b5-1 trading plan

Purchase increased prior direct holdings by approximately 0.81%; approximately 579K shares afterward

Calculated transaction value approximately US$4.92K
BETA

BETA Technologies, Inc.

Total value ≈ US$1.11M

6 transaction rows · 2 filings

Clark Kyle

Sale
Officer / Director disclosed sale of 10,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.08M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$184.02K

Clark Kyle

Sale
Officer / Director disclosed sale of 10,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.07M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$185.06K
Show 4 more transaction rows

Clark Kyle

Sale
Officer / Director disclosed sale of 10,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.06M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$181.11K

Clark Kyle

Sale
Officer / Director disclosed sale of 10,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.11M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$199.08K

Clark Kyle

Sale
Officer / Director disclosed sale of 10,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.1M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$185.31K

Clark Kyle

Sale
Officer / Director disclosed sale of 10,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 5.09M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$175.79K
PLTR

Palantir Technologies Inc.

Total value ≈ US$3.37M

9 transaction rows · 2 filings

Moore Alexander D.

Sale
Director disclosed sale of 600 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.06M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$116.05K

Moore Alexander D.

Sale
Director disclosed sale of 1,600 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.06M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$312.21K
Show 7 more transaction rows

Moore Alexander D.

Sale
Director disclosed sale of 2,400 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.06M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$470.13K

Moore Alexander D.

Sale
Director disclosed sale of 900 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.06M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$177.12K

Moore Alexander D.

Sale
Director disclosed sale of 2,700 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.05M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$534.94K

Moore Alexander D.

Sale
Director disclosed sale of 3,500 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.05M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$696.74K

Moore Alexander D.

Sale
Director disclosed sale of 4,200 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.05M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$840.61K

Moore Alexander D.

Sale
Director disclosed sale of 100 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 1.05M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$20.07K

Woersching Eric H.

Sale
Director disclosed sale of 1,000 shares

Disclosed 10b5-1 trading plan

Sale represented approximately 22.39% of prior direct holdings; approximately 3.47K shares remain

Calculated transaction value approximately US$205K
WSE

Wise Group plc

Total value ≈ US$1.25M

3 transaction rows · 3 filings

Thomassin Emmanuel Francois Jean-Claude Laurent

Sale
CFO / Director disclosed sale of 6,040 shares

Filing did not check the 10b5-1 plan indicator

Approximately 4.85K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$70.97K

Sinha Harsh

Sale
Officer disclosed sale of 42,324 shares

Filing did not check the 10b5-1 plan indicator

Approximately 979K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$497.31K
Show 1 more transaction rows

Peiris Nilan

Sale
Officer disclosed sale of 58,262 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.52M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$684.58K
IAM

Iambic Therapeutics, Inc.

Total value ≈ US$11.5M

1 transaction rows · 1 filings

Rachlin Evan Lockwood

Purchase
Director disclosed purchase of 718,750 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.59M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$11.5M
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗